Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Fluorouracil × Breast × Clear all

Phase

Status

Completed 67 Unknown 21 Terminated 11 Active not recruiting 5 Recruiting 3 Suspended 2 Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 45 Head & Neck 7 Dermatologic 5 Thoracic 2 Tumor-Agnostic 1 Lymphoid 1 Genitourinary 1 Breast 1

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Paclitaxel 22 Trastuzumab 18 Cyclophosphamide 15 Docetaxel 14 Letrozole 10 Fulvestrant 10 Doxorubicin 10 Capecitabine 10 Radiotherapy 9 Carboplatin 9 pembrolizumab 8 exemestane 8 Magnetic Resonance Spectroscopy 7 Lapatinib 7 Anastrozole 7 palbociclib 6 eribulin 6 abemaciclib 6 Goserelin 6 Aromatase Inhibitors 6 Therapeutics 5 Taxes 5 Neoadjuvant Therapy 5 Mastectomy, Segmental 5 Drug Therapy 5 Cryosurgery 5 Chemotherapy, Adjuvant 5 Biopsy 5 Bevacizumab 5 tucatinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03554109 2025-02-21

TNBC

ImmunityBio, Inc.

Phase 2 Withdrawn

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡